Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.

Siddharth Chhajlani, Jelka Kuiper, Philippe Beutels, Ivan Borbath, Wouter Dercksen, Christophe M Deroose, Stella Heemskerk, Suzanne Polinder, Ella Roelant, Elke Smits, Iris Verhaegen, Isolde Van der Massen

BMJ open

2025

Journal Article, Clinical Trial Protocol

Humans, Neuroendocrine Tumors, Pancreatic Neoplasms, Intestinal Neoplasms, Stomach Neoplasms, Somatostatin, Disease Progression, Everolimus, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Octreotide, Progression-Free Survival, Sunitinib, Antineoplastic Agents, Pragmatic Clinical Trials as Topic